Sarepta Therapeutics (SRPT)

• Market cap: $1.83B
• 1 day: -1.13%
• 5 days: -28.14%
• 1 month: -24.57%
• 3 months: -2.9%
• 6 months: -52.51%
• Year to date: -85.95%
• 1 year: -85.52%
• 5 years: -86.11%
• 10 years: -33.56%
• Sector: Healthcare
• Industry: Biotechnology

About: Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

Employees: 1,372